CFIC
LJPC

City Financial Investment Company’s La Jolla Pharmaceutical Company LJPC Stock Holding History

City Financial Investment Company’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-28,188
Closed -$494K – 89
2016
Q4 		$494K Buy
+28,188
New +$540K 0.09% 55

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

City Financial Investment Company's LJPC Position: Q1 2017 in Review

City Financial Investment Company sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2017, closing a stake of 28,188 shares — an estimated $494K sold.

City Financial Investment Company first reported a position in LJPC in Q4 2016 and held it in 1 quarter. The position peaked at $494K in Q4 2016. 96 funds tracked by Wall St. Rank hold LJPC as of Q1 2017.

  • City Financial Investment Company reported no remaining La Jolla Pharmaceutical Company position as of Q1 2017 after selling out during the quarter.
  • City Financial Investment Company sold 28,188 La Jolla Pharmaceutical Company shares in Q1 2017, an estimated $494K.
  • City Financial Investment Company first reported a position in La Jolla Pharmaceutical Company in Q4 2016 and held it in 1 quarter.
  • City Financial Investment Company's La Jolla Pharmaceutical Company position peaked at $494K in Q4 2016.
  • 96 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2017.

Based on City Financial Investment Company's 13F filing for Q1 2017, filed 15 May 2017.